Related Experiment Video
Updated: Aug 8, 2026
06:21
Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform
Published on: May 10, 2024
In silico pharmacogenetics of warfarin metabolism
Yingying Guo1, Paul Weller, Erin Farrell
1Department of Genetics and Genomics, Roche Palo Alto S3-1, 3431 Hillview Ave., Palo Alto, California 94304, USA.
Nature Biotechnology
|May 9, 2006
Summary
Computational genetic analysis in mice identified a key factor regulating warfarin metabolism. This approach aids in predicting individual drug responses and optimizing anticoagulant therapy.
Area of Science:
- Pharmacogenetics
- Drug Metabolism
- Computational Biology
Background:
- Individual responses to warfarin, an anticoagulant, vary significantly due to genetic factors.
- Predicting these differences is crucial for safe and effective therapeutic interventions.
Purpose of the Study:
- To identify genetic factors influencing warfarin metabolism using a murine haplotype-based computational method.
- To correlate genetic variations with pharmacokinetic differences in drug metabolism.
Main Methods:
- Quantified warfarin and metabolites in 13 inbred mouse strains.
- Correlated metabolite accumulation with genetic variation in cytochrome P450 2C (Cyp2c) genes.
- Experimentally validated findings using isoform-specific inhibitors and recombinant enzymes.
Main Results:
- Identified a genetic factor regulating warfarin metabolism to 7-hydroxywarfarin.
- Confirmed the role of Cyp2c29 in this metabolic pathway.
- Demonstrated the utility of computational genetic analysis for identifying drug metabolism genes.
Conclusions:
- Computational genetic analysis is effective for identifying genetic variants impacting drug metabolism.
- This method can help predict interindividual pharmacokinetic differences.
- Findings contribute to personalized medicine approaches for warfarin therapy.
Related Concept Videos
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:28Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...